The University of Southampton
University of Southampton Institutional Repository

Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians

Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians
Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians
Introduction: Observational studies suggest that starting oral anticoagulation (OAC) after intracranial haemorrhage (ICH) is beneficial, but a randomised controlled trial (RCT) is needed to confirm this. We assessed opinion about this treatment uncertainty amongst stroke physicians in the UK. Method: In May 2015, we used Survey Monkey to email an online questionnaire to 289 doctors on the delegation logs at 111 hospital sites participating in the REstart or STop Antithrombotics Randomised Trial (www.RESTARTtrial.org; ISRCTN71907627), followed by 3 email reminders to non-responders. Results: Of 289 invitees, one had opted out of Survey Monkey, 17 emails bounced, 109 (38%) did not respond, and 15 partially completed the survey, leaving 147 (51%) complete responses. 95% of respondents were uncertain whether to start OAC in at least some patients with indications for OAC after ICH. Physicians would randomise patients with atrial fibrillation (AF) and a CHA2DS2-VASc score >1 (88%), recurrent venous thromboembolism (78%) or other cardiac indications (80%). One quarter of respondents would prefer to use adjusted dose warfarin and the rest would use a new OAC (of whom 50% would use apixaban and 29% would use any new OAC). In a RCT the preferred comparator was avoidance of all antithrombotic drugs for patients with lone AF (73%) and an antiplatelet drug for patients with a past history of vaso-occlusive disease (89%). 82% of respondents were just as, or more, keen to participate in RESTART-OAC than RESTART-antiplatelets. Discussion: Equipoise about starting OAC after ICH and physicians' keenness to participate support the need for RESTART-OAC.
Journal: Conference Abstract *cerebrovascular acci
1747-4930
28-29
Marigold, Richard
23c9f4cc-a1da-41a0-84bd-8e1aee91ed78
British Association of Stroke Physicians
Marigold, Richard
23c9f4cc-a1da-41a0-84bd-8e1aee91ed78

Marigold, Richard , British Association of Stroke Physicians (2015) Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians. International Journal of Stroke, 10, 28-29.

Record type: Article

Abstract

Introduction: Observational studies suggest that starting oral anticoagulation (OAC) after intracranial haemorrhage (ICH) is beneficial, but a randomised controlled trial (RCT) is needed to confirm this. We assessed opinion about this treatment uncertainty amongst stroke physicians in the UK. Method: In May 2015, we used Survey Monkey to email an online questionnaire to 289 doctors on the delegation logs at 111 hospital sites participating in the REstart or STop Antithrombotics Randomised Trial (www.RESTARTtrial.org; ISRCTN71907627), followed by 3 email reminders to non-responders. Results: Of 289 invitees, one had opted out of Survey Monkey, 17 emails bounced, 109 (38%) did not respond, and 15 partially completed the survey, leaving 147 (51%) complete responses. 95% of respondents were uncertain whether to start OAC in at least some patients with indications for OAC after ICH. Physicians would randomise patients with atrial fibrillation (AF) and a CHA2DS2-VASc score >1 (88%), recurrent venous thromboembolism (78%) or other cardiac indications (80%). One quarter of respondents would prefer to use adjusted dose warfarin and the rest would use a new OAC (of whom 50% would use apixaban and 29% would use any new OAC). In a RCT the preferred comparator was avoidance of all antithrombotic drugs for patients with lone AF (73%) and an antiplatelet drug for patients with a past history of vaso-occlusive disease (89%). 82% of respondents were just as, or more, keen to participate in RESTART-OAC than RESTART-antiplatelets. Discussion: Equipoise about starting OAC after ICH and physicians' keenness to participate support the need for RESTART-OAC.

This record has no associated files available for download.

More information

Published date: 2015
Keywords: Journal: Conference Abstract *cerebrovascular acci

Identifiers

Local EPrints ID: 506229
URI: http://eprints.soton.ac.uk/id/eprint/506229
ISSN: 1747-4930
PURE UUID: e95b7882-59a5-4ee5-a033-aa66f0aae792

Catalogue record

Date deposited: 30 Oct 2025 17:46
Last modified: 30 Oct 2025 17:46

Export record

Contributors

Author: Richard Marigold
Corporate Author: British Association of Stroke Physicians

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×